|
Impact of Patient-Related Factors on the Pharmacokinetics of Bulevirtide
|
|
|
EASL 2022 June 22-26 London
Renu Singh,1 Parag Kumar,1 Rory Leisegeng,1 Francesco Bellanti,2 Craig Comisar,2 Kishore Polireddy,2 Vithika Suri,1 Dmitry Manuilov,1 John Flaherty,1 Sandhya Girish1
1Gilead Sciences, Inc., Foster City, California, USA; 2Certara Netherlands B.V., Amsterdam, the Netherlands
![0701221](../images/070122/070122-7/0701221.gif)
![0701222](../images/070122/070122-7/0701222.gif)
![0701223](../images/070122/070122-7/0701223.gif)
![0701224](../images/070122/070122-7/0701224.gif)
![0701225](../images/070122/070122-7/0701225.gif)
![0701226](../images/070122/070122-7/0701226.gif)
|
|
|
|
|
|
|